CMTA-STAR Funding
CMTA-STAR Funding from the Charcot-Marie-Tooth Association supports expert-reviewed research advancing therapies for Charcot-Marie-Tooth disease.
Funder: Charcot-Marie-Tooth Association
Due Dates (Anticipated): January 2027 (Step 1 pre-proposal) | January 2027 (Step 2 full proposal, two weeks after Step 1 invitation)
Funding Amounts: Award size varies; indirect costs capped at 10% of total project budget.
Summary: Supports innovative, expert-reviewed research advancing treatments for Charcot-Marie-Tooth disease.
Key Information: Invitation-only; proposals must align with priority areas and follow a two-stage process.
Description
The Charcot-Marie-Tooth Association (CMTA) offers funding through its Strategy To Accelerate Research (STAR) program to support innovative research projects that advance treatments for Charcot-Marie-Tooth (CMT) disease. Projects are evaluated through a rigorous, multi-stage review process by scientific, therapeutic, and clinical advisory boards. The program prioritizes research with strong scientific merit, translational potential, and the capacity to make a meaningful impact on CMT therapy development. Funding is by invitation only—CMTA’s Board of Directors or Chief Research Officer seeks out and invites targeted proposals in priority research areas.
